{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:37:07Z","timestamp":1781609827523,"version":"3.54.5"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1007\/bf02253465","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T12:24:22Z","timestamp":1132662262000},"page":"153-172","source":"Crossref","is-referenced-by-count":88,"title":["Thromboxanes: Synthase and receptors"],"prefix":"10.1186","volume":"5","author":[{"given":"Rong-Fong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hsiung","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02253465_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI118108","volume":"96","author":"J Abe","year":"1995","unstructured":"Abe J, Takeguchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K. Rat kidney thromboxane receptor: Molecular cloning, signal transduction and intrarenal expression localization. J Clin Invest 96:657\u2013664;1995.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR2","doi-asserted-by":"crossref","first-page":"17397","DOI":"10.1016\/S0021-9258(19)85348-6","volume":"268","author":"S Ali","year":"1993","unstructured":"Ali S, Davis MG, Becker MW, Dorn GW. Thromboxane A2 stimulates vascular smooth muscle hypertrophy by unregulating the synthesis and release of endogenous basic fibroblast growth factor. J Biol Chem 268:17397\u201317403;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR3","first-page":"1132","volume":"277","author":"CJ Allan","year":"1996","unstructured":"Allan CJ, Higashiura K, Martin M, Morinelli TA, Kurtz DT, Geoffroy O, Meier GA, Gettys TW, Halushka PV. Characterization of the cloned HEL cell thromboxane A2 receptor: Evidence that the affinity state can be altered by G\u03b113 and G\u03b1q. J Pharmacol Exp Ther 277:1132\u20131139;1996.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/362722a0","volume":"362","author":"NC Andrews","year":"1993","unstructured":"Andrews, NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362:722\u2013770;1993.","journal-title":"Nature"},{"key":"BF02253465_CR5","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.90.24.11488","volume":"90","author":"NC Andrews","year":"1993","unstructured":"Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst P, Orkin SH. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci USA 90:11488\u201311492;1993.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(87)90611-8","volume":"49","author":"P Angel","year":"1987","unstructured":"Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Ramdsorf HJ, Jonat C, Herrilich P, Karin M. Phorbol-ester inducible genes contain a common cis-element recognized by a TPA-modulated transacting factor. Cell 49:729\u2013739;1987.","journal-title":"Cell"},{"key":"BF02253465_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0163-7827(89)90002-7","volume":"28","author":"H Arita","year":"1989","unstructured":"Arita H, Nakano T, Hanasaki K. Thromboxane A2: Its generation and role in platelet activation. Prog Lipid Res 28:273\u2013301;1989.","journal-title":"Prog Lipid Res"},{"key":"BF02253465_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-1119(95)00881-0","volume":"173","author":"SJ Baek","year":"1996","unstructured":"Baek SJ, Lee K-D, Shen R-F. Genomic structure and polymorphism of the human thromboxane synthase-encoding gene. Gene 173:251\u2013256;1996.","journal-title":"Gene"},{"key":"BF02253465_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/bj2910235","volume":"291","author":"JJ Baldassare","year":"1993","unstructured":"Baldassare JJ, Tarver AP, Henderson PA, Mackin WM, Sahagan B, Fisher GJ. Reconstitution of thromboxane A2 in receptor stimulated phosphoinositide hydrolysis in isolated platelet membranes: Involvement of phospho-inositide-specific phospholipase C-b and GTP-binding protein Gq. Biochem J 291:235\u2013240;1993.","journal-title":"Biochem J"},{"key":"BF02253465_CR10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/315511a0","volume":"315","author":"SS Bhagwat","year":"1985","unstructured":"Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FA. Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature 315:511\u2013513;1985.","journal-title":"Nature"},{"key":"BF02253465_CR11","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1016\/S0021-9258(17)37576-2","volume":"269","author":"C Borg","year":"1994","unstructured":"Borg C, Lim CT, Yeomans DC, Dieter JP, Kamiotis D, Anderson EG, LeBreton GC. Purification of rat brain, rabbit aorta and human platelet thromboxane A2\/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. J Biol Chem 269:6109\u20136116;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI112947","volume":"79","author":"LF Brass","year":"1987","unstructured":"Brass LF, Shaller CC, Belmonte EJ. Inositol-1,4,5-triphosphate induced granule secretion in platelets: Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein dependent mechanism distinct from that of thrombin. J Clin Invest 79:1269\u20131275;1987.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR13","unstructured":"Brewster AG, Brown GR, Jessup R, Smithers MJ, Stocker A. In Abstr 7th International Conference on Prostaglandins and Related Compounds, Florence, 1990."},{"key":"BF02253465_CR14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0090-6980(76)90125-8","volume":"12","author":"SR Bunting","year":"1976","unstructured":"Bunting SR, Gryglewski S, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 12:897\u2013915;1976.","journal-title":"Prostaglandins"},{"key":"BF02253465_CR15","first-page":"441","volume":"222","author":"LC Casey","year":"1982","unstructured":"Casey LC, Fletcher JR, Zmudka MI, Ramwell PW. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY-1581. J Pharmacol Exp Ther 222:441\u2013446;1982.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR16","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1073\/pnas.90.23.11371","volume":"90","author":"JY Chan","year":"1993","unstructured":"Chan JY, Han X-L, Kan YW. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci USA 90:11371\u201311375;1993.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR17","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.8079172","volume":"265","author":"AK Chaudhary","year":"1994","unstructured":"Chaudhary AK, Nokubo M, Ramachandra R, Yeola SN, Morrow JD, Alair IA, Marnett LJ. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 265:1580\u20131582;1994.","journal-title":"Science"},{"key":"BF02253465_CR18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.36.4.466","volume":"36","author":"ST Chen","year":"1986","unstructured":"Chen ST, Hsu CY, Hogan EL, Halushka PV, Linet OI, Yatsu FM. Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology 36:466\u2013470;1986.","journal-title":"Neurology"},{"key":"BF02253465_CR19","unstructured":"Chiang N. Molecular analysis of the structure and ligand binding relationship of thromboxane A2 receptors; PhD Diss, University of Kentucky, 88\u201390;1996."},{"key":"BF02253465_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/abbi.1996.0423","volume":"334","author":"N Chiang","year":"1996","unstructured":"Chiang N, Kan WN, Tai HH. Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Arch Biochem Biophys 334:9\u201317;1996.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR21","unstructured":"Chiang N, Tai HH. The role of N-glycosylation of human platelet thromboxane A2 receptor in ligand binding. Arch Biochem Biophys, in press."},{"key":"BF02253465_CR22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.1981.tb16814.x","volume":"73","author":"RA Coleman","year":"1981","unstructured":"Coleman RA, Humphrey PPA, Kennedy I, Levy CP, Lumley P. Comparison on the actions of U-46619, a prostaglandin H2 analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73:773\u2013778;1981.","journal-title":"Br J Pharmacol"},{"key":"BF02253465_CR23","first-page":"1034","volume":"271","author":"DD D'Angelo","year":"1994","unstructured":"D'Angelo DD, Davis MG, Ali S, Dorn GW. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells. J Pharmacol Exp Ther 271:1034\u20131041;1994.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.RES.77.3.466","volume":"77","author":"DD D'Angelo","year":"1995","unstructured":"D'Angelo DD, Davis MG, Houser WA, Eubank JJ, Ritchie ME, Dorn GW. Characterization of 5\u2032 end of human thromboxane receptor gene: Organization analysis and mapping of protein kinase C-response elements regulating expression in platelets. Circ Res 77:466\u2013474;1995.","journal-title":"Circ Res"},{"key":"BF02253465_CR25","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.271.11.6233","volume":"271","author":"DD D'Angelo","year":"1996","unstructured":"D'Angelo DD, Eubank JJ, Davis MG, Dorn GW. Mutagenic analysis of platelet thromboxane receptor cysteines: Role in ligand binding and receptor effector coupling. J Biol Chem 271:6233\u20136240;1996.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0090-6980(96)00091-3","volume":"52","author":"DD D'Angelo","year":"1996","unstructured":"D'Angelo DD, Terasawa T, Carlisle SJ, Dorn GW, Lynch KR. Characterization of a rat kidney thromboxane A2 receptor: High affinity for agonist ligand I-BOP. Prostaglandins 52:303\u2013316;1996.","journal-title":"Prostaglandins"},{"key":"BF02253465_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0038-1646523","volume":"61","author":"F DeClerck","year":"1989","unstructured":"DeClerck F, Beetens J, Dechaffoy de Courcelles D, Freyne E, Janssen PAJ. R68070: Thromboxane synthetase inhibition and thromboxane A2\/prostaglandin endoperoxide receptor blockade, combined in one molecule. I. Biochemical profile in vitro. Thromb Haemost 61:35\u201342;1989.","journal-title":"Thromb Haemost"},{"key":"BF02253465_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(77)80704-7","volume":"84","author":"U Diczfalusy","year":"1977","unstructured":"Diczfalusy U, Falardeau P, Hammarstrom S. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthetase. FEBS Lett 84:271\u2013274;1977.","journal-title":"FEBS Lett"},{"key":"BF02253465_CR29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-5793(77)80896-X","volume":"82","author":"U Diczfalusy","year":"1977","unstructured":"Diczfalusy U, Hammarstrom S. Inhibitors of thromboxane synthase in human platelets. FEBS Lett 82:108\u2013110;1977.","journal-title":"FEBS Lett"},{"key":"BF02253465_CR30","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1002\/j.1460-2075.1987.tb02645.x","volume":"6","author":"RAF Dixon","year":"1987","unstructured":"Dixon RAF, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD. Structural features required for ligand binding to the b-adrenergic receptor. EMBO J 6:3269\u20133275;1987.","journal-title":"EMBO J"},{"key":"BF02253465_CR31","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198405313102203","volume":"310","author":"JV Donadio","year":"1984","unstructured":"Donadio JV, Anderson CF, Mitchell JC III, Holley KE, Ilstrap DM, Fuster V, Chesebro JH. Membranoproliferative Glomerulonephritis. A prospective trial of platelet-inhibitor therapy. N Engl J Med 310:1421\u20131426;1984.","journal-title":"N Engl J Med"},{"key":"BF02253465_CR32","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1172\/JCI114375","volume":"84","author":"GW Dorn","year":"1989","unstructured":"Dorn GW. Distinct platelet thromboxane A2\/prostaglandin H2 receptor subtypes: A radioligand binding study of human platelets. J Clin Invest 84:1883\u20131891;1989.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-291X(89)92118-9","volume":"163","author":"GW Dorn","year":"1989","unstructured":"Dorn GW. Isoelectric and mass characterization of human platelet thromboxane A2\/prostaglandin H2 receptors. Biochem Biophys Res Commun 163:183\u2013188;1989.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR34","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1016\/S0021-9258(19)39553-5","volume":"265","author":"GW Dorn","year":"1990","unstructured":"Dorn GW. Cyclic oxidation-reduction reactions regulate thromboxane A2\/prostaglandin H2 receptor number and affinity in human platelet membranes. J Biol Chem 265:4240\u20134246;1990.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR35","first-page":"228","volume":"259","author":"GW Dorn","year":"1991","unstructured":"Dorn GW. Mechanism for homologous down regulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells. J Pharmacol Exp Ther 259:228\u2013234;1991.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR36","doi-asserted-by":"crossref","first-page":"C991","DOI":"10.1152\/ajpcell.1992.262.4.C991","volume":"262","author":"GW Dorn","year":"1992","unstructured":"Dorn GW. Regulation of response to thromboxane A2 in CHRF-288 megakaryotic cells. Am J Physiol 262:C991-C999;1992.","journal-title":"Am J Physiol"},{"key":"BF02253465_CR37","first-page":"447","volume":"265","author":"GW Dorn","year":"1993","unstructured":"Dorn GW, Becker MW. Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther 265:447\u2013456;1993.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR38","doi-asserted-by":"crossref","first-page":"12399","DOI":"10.1074\/jbc.272.19.12399","volume":"272","author":"GW Dorn","year":"1997","unstructured":"Dorn GW, Davis MG, D'Angelo DD. Structural determinants for agonist binding affinity to thromboxane\/prostaglandin endoperoxide (TP) receptors: Analysis of chimeric rat\/human TP receptors. J Biol Chem 272:12399\u201312405;1997.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.CIR.81.1.212","volume":"81","author":"GW Dorn","year":"1990","unstructured":"Dorn GW, Liel N, Trask JL, Mais DE, Assey ME, Halushka PV. Increased platelet thromboxane A2\/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation 81:212\u2013218;1990.","journal-title":"Circulation"},{"key":"BF02253465_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1152\/jappl.1985.58.1.34","volume":"58","author":"IS Farrukh","year":"1985","unstructured":"Farrukh IS, Michael JR, Summer WR, Adkinson NF Jr, Gurtner GH. Thromboxane-induced pulmonary vasoconstriction. Involvement of calcium. J Appl Physiol 58:34\u201344;1985.","journal-title":"J Appl Physiol"},{"key":"BF02253465_CR41","first-page":"20","volume":"38","author":"V Ferraris","year":"1977","unstructured":"Ferraris V, Smith JB, Silver MJ. Radioimmunoassay of thromboxane B2. Thromb Haemostasis 38:20\u201321;1977.","journal-title":"Thromb Haemostasis"},{"issue":"suppl I","key":"BF02253465_CR42","first-page":"169","volume":"81","author":"GI Fiddle","year":"1990","unstructured":"Fiddle GI, Lumley P. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. Circulation 81(suppl I):169\u2013178;1990.","journal-title":"Circulation"},{"key":"BF02253465_CR43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI112329","volume":"77","author":"DJ Fitzgerald","year":"1986","unstructured":"Fitzgerald DJ, Doran J, Jackson E, FitzGerald GA. Coronary vascular occlusion mediated via thromboxane A2\/prostaglandin endoperoxide receptor activation in vitro. J Clin Invest 77:496\u2013503;1986.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0140-6736(90)90869-7","volume":"335","author":"DJ Fitzgerald","year":"1990","unstructured":"Fitzgerald DJ, Rocki W, Murray R, Mayo G, FitzGerald GA. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335:751\u2013754;1990.","journal-title":"Lancet"},{"key":"BF02253465_CR45","first-page":"154","volume":"46","author":"GA FitzGerald","year":"1987","unstructured":"FitzGerald GA, Healy C, Daugherty J. Thromboxane A2 biosynthesis in human diseases. Fed Proc 46:154\u2013158;1987.","journal-title":"Fed Proc"},{"key":"BF02253465_CR46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.72.6.1194","volume":"72","author":"GA FitzGerald","year":"1985","unstructured":"FitzGerald GA, Reilly IA, Pederson AK. The biochemical pharmacology of thromboxane synthetase inhibition in man. Circulation 72:1194\u20131201;1985.","journal-title":"Circulation"},{"key":"BF02253465_CR47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0005-2760(79)90057-2","volume":"573","author":"F Fitzpatrick","year":"1979","unstructured":"Fitzpatrick F, Gorman R, Bundy G, Honohan T, McGuire J, Sun F. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor. Biochim Biophys Acta 573:238\u2013244;1979.","journal-title":"Biochim Biophys Acta"},{"key":"BF02253465_CR48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.13.3.421","volume":"13","author":"I Foulon","year":"1993","unstructured":"Foulon I, Bachir D, Galacteros F, Maclouf J. Increase in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to thromboxane A2 agonist U-46619. Arterioscler Thromb 13:421\u2013426;1993.","journal-title":"Arterioscler Thromb"},{"key":"BF02253465_CR49","first-page":"934","volume":"44","author":"CD Funk","year":"1993","unstructured":"Funk CD, Furcho L, Movan N, FitzGerald GA. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol 44:934\u2013939;1993.","journal-title":"Mol Pharmacol"},{"key":"BF02253465_CR50","first-page":"74","volume":"258","author":"L Furci","year":"1991","unstructured":"Furci L, Fitzgerald DJ, FitzGerald GA. Heterogeneity of prostaglandin H2\/thromboxane A2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 258:74\u201381;1991.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR51","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1073\/pnas.74.9.4007","volume":"74","author":"RR Gorman","year":"1977","unstructured":"Gorman RR, Bundy GL, Peterson DC, Sun FF, Miller OV, Fitzpatrick FA. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid. Proc Natl Acad Sci USA 74:4007\u20134013;1977.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI112900","volume":"79","author":"M Goerig","year":"1987","unstructured":"Goerig M, Habenicht AJR, Heits R, Zeh W, Katus H, Kommerell B, Ziegler R, Glomset JA. sn-1,2-diacylglycerol and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cell. J Clin Invest 79:903\u2013911;1987.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR53","doi-asserted-by":"crossref","first-page":"19484","DOI":"10.1016\/S0021-9258(19)77644-3","volume":"263","author":"M Goerig","year":"1988","unstructured":"Goerig M, Habenicht AJR, Zeh W, Salbach P, Kommerell B, Rothe DER, Nastainczyk W, Glomset JA. Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils. J Biol Chem 263:19484\u201319391;1988.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0165-6147(91)90533-X","volume":"121","author":"P Gresele","year":"1991","unstructured":"Gresele P, Deckmyn H, Giuseppe G, Neuci GG, Vermylen J. Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders. Trends Pharmacol Sci 121:158\u2013163;1991.","journal-title":"Trends Pharmacol Sci"},{"key":"BF02253465_CR55","first-page":"42","volume":"35","author":"RA Gunther","year":"1984","unstructured":"Gunther RA, Smith GJ, Holcroft JW. Pulmonary response to selective inhibition of thromboxane A2 synthesis during endotoxemia utilizing a unique inhibitor. Surg Forum 35:42\u201344;1984.","journal-title":"Surg Forum"},{"key":"BF02253465_CR56","first-page":"857","volume":"46","author":"JG Hall","year":"1990","unstructured":"Hall JG. Genomic imprinting: Review and relevance to human diseases. Am J Hum Genet 46:857\u2013873;1990.","journal-title":"Am J Hum Genet"},{"key":"BF02253465_CR57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0929-7855(95)00023-J","volume":"12","author":"PV Halushka","year":"1995","unstructured":"Halushka PV, Allan CJ, Davis-Bruno KL. Thromboxane A2 receptors. J Lipid Mediators Cell Signalling 12:361\u2013378;1995.","journal-title":"J Lipid Mediators Cell Signalling"},{"key":"BF02253465_CR58","first-page":"149","volume":"46","author":"PV Halushka","year":"1987","unstructured":"Halushka PV, Mais DE, Saussy DL. Platelet and vascular smooth muscle thromboxane A2\/prostaglandin H2 receptors. Fed Proc 46:149\u2013153;1987.","journal-title":"Fed Proc"},{"key":"BF02253465_CR59","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1073\/pnas.70.3.899","volume":"70","author":"M Hamberg","year":"1973","unstructured":"Hamberg M, Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70:890\u2013903;1973.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR60","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1073\/pnas.71.9.3400","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71:3400\u20133404;1974.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR61","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","volume":"72","author":"M Hamberg","year":"1975","unstructured":"Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994\u20132998;1975.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.71.2.345","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 71:345\u2013349;1974.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0049-3848(88)90266-6","volume":"50","author":"K Hanasaki","year":"1988","unstructured":"Hanasaki K, Arita H. Characterization of a new compound, S-145, as a specific TXA2 receptor anatagonist in platelets. Thromb Res 50:305\u2013376;1988.","journal-title":"Thromb Res"},{"key":"BF02253465_CR64","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/0006-2952(90)90096-4","volume":"40","author":"K Hanasaki","year":"1990","unstructured":"Hanasaki K, Nakano T, Arita H. Receptor mediated mitogen effect of thromboxane A2 in vascular smooth muscle cells. Biochem Pharmacol 40:2535\u20132542;1990.","journal-title":"Biochem Pharmacol"},{"key":"BF02253465_CR65","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/0006-2952(89)90004-X","volume":"38","author":"K Hanasaki","year":"1989","unstructured":"Hanasaki K, Nakano K, Kasai H, Arita H. Biochemical characterization and comparison of rat thromboxane A2\/prostaglandin H2 receptors in platelets and cultures aortic smooth muscle cells. Biochem Pharmacol 38:2967\u20132976;1989.","journal-title":"Biochem Pharmacol"},{"key":"BF02253465_CR66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-291X(90)91954-Q","volume":"166","author":"N Harada","year":"1990","unstructured":"Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun 166:365\u2013372;1990.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1432-1033.1993.tb18412.x","volume":"218","author":"H Hashimoto","year":"1993","unstructured":"Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T. Gene structure of CYP3A4, an adult-specific form of cytochrome P-450 in human livers, and its transcriptional control. Eur J Biochem 218:585\u2013595;1993.","journal-title":"Eur J Biochem"},{"key":"BF02253465_CR68","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1016\/S0021-9258(18)95702-9","volume":"260","author":"M Haurand","year":"1985","unstructured":"Haurand M, Ullrich V. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome p-450 enzyme. J Biol Chem 260:15059\u201315067;1985.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9258(17)31235-8","volume":"264","author":"M Hecker","year":"1989","unstructured":"Hecker M, Ullrich V. On the mechanism of PGI2 and TxA2 biosynthesis. J Biol Chem 264:141\u2013150;1989.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR70","first-page":"1765","volume":"4","author":"BD Hendrich","year":"1995","unstructured":"Hendrich BD, Willard HF. Epigenetic regulation of gene expression: The effect of altered chromatin structure from yeast to mammals. Mol Genet 4:1765\u20131777;1995.","journal-title":"Mol Genet"},{"key":"BF02253465_CR71","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","volume":"349","author":"M Hirata","year":"1991","unstructured":"Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kagayama R, Nakanishi S, Narumiya S. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349:617\u2013620;1991.","journal-title":"Nature"},{"key":"BF02253465_CR72","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI117510","volume":"94","author":"T Hirata","year":"1994","unstructured":"Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 94:1662\u20131667;1994.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR73","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1212\/WNL.35.7.1003","volume":"35","author":"CY Hsu","year":"1985","unstructured":"Hsu CY, Halushka PV, Hogan EL, Banik NL, Lee WA, Perot PL. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology 35:1003\u20131009;1985.","journal-title":"Neurology"},{"key":"BF02253465_CR74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj3070493","volume":"306","author":"CF Huang","year":"1995","unstructured":"Huang CF, Tai HH. Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. Biochem J 306:493\u2013498;1995.","journal-title":"Biochem J"},{"key":"BF02253465_CR75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-5793(92)80990-X","volume":"306","author":"H Ihara","year":"1992","unstructured":"Ihara H, Yokoyama C, Miyata A, Kosaka T, N\u00fcsing R, Ullrich V, Tanabe T. Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester. FEBS Lett 306:161\u2013164;1992.","journal-title":"FEBS Lett"},{"key":"BF02253465_CR76","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1172\/JCI110157","volume":"67","author":"C Ingerman-Wojenski","year":"1981","unstructured":"Ingerman-Wojenski C, Siliver MJ, Smith JB, Macarak E. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 67:1292\u20131296;1981.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR77","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1021\/jm00306a013","volume":"12","author":"AL Johnson","year":"1969","unstructured":"Johnson AL, Kauer JC, Sharma DC, Dorfman RI. The synthesis of 1-arylimidazole, a new class of steroid hydroxylation inhibitors. J Med Chem 12:1024\u20131028;1969.","journal-title":"J Med Chem"},{"key":"BF02253465_CR78","doi-asserted-by":"crossref","first-page":"23510","DOI":"10.1016\/S0021-9258(18)54527-0","volume":"34","author":"DA Jones","year":"1991","unstructured":"Jones DA, Fitzpatrick FA. Thromboxane A2 synthase: Modification during \u2018suicide\u2019 inactivation. J Biol Chem 34:23510\u201323514;1991.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.1981.tb10447.x","volume":"73","author":"RL Jones","year":"1981","unstructured":"Jones RL, Wilson NM. Thromboxane receptor antagonism shown by a prostanoid with a bicyclo [2.2.1] hepatane ring. Br J Pharmacol 73:220\u2013221;1981.","journal-title":"Br J Pharmacol"},{"key":"BF02253465_CR80","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1476-5381.1981.tb08744.x","volume":"73","author":"JN Karanian","year":"1981","unstructured":"Karanian JN, Ramey ER, Ramwell PW. Effect of gender on development and diurnal rhythm of prostaglandin receptors in rat aorta. Br J Pharmacol 73:903\u2013907;1981.","journal-title":"Br J Pharmacol"},{"key":"BF02253465_CR81","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0968-0004(92)90012-X","volume":"17","author":"M Karin","year":"1992","unstructured":"Karin M, Smeal T. Control of transcription factors by signal transduction pathways: The beginning of the end. Trends Biochem Sci 17:418\u2013422;1992.","journal-title":"Trends Biochem Sci"},{"key":"BF02253465_CR82","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0167-4889(94)00225-4","volume":"1265","author":"J Katanaka","year":"1995","unstructured":"Katanaka J, Hashimoto H, Sutimoto Y, Sawada M, Negishi M, Suzumura A, Marunouchi T, Ichikawa A, Baba A. cDNA cloning of a thromboxane A2 receptor from rat astrocytes. Biochim Biophys Acta 1265:220\u2013223;1995.","journal-title":"Biochim Biophys Acta"},{"key":"BF02253465_CR83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0090-6980(93)90085-L","volume":"45","author":"JC Keith","year":"1993","unstructured":"Keith JC, Spitz B, Van Assche FA. Thromboxane synthase inhibition as a new therapy for preeclampsia: Animal and human studies minireview. Prostaglandins 45:3\u201313;1993.","journal-title":"Prostaglandins"},{"key":"BF02253465_CR84","doi-asserted-by":"crossref","first-page":"29914","DOI":"10.1016\/S0021-9258(18)43968-3","volume":"269","author":"CT Kinsella","year":"1994","unstructured":"Kinsella CT, O'Mahony DJ, FitzGerald GA. Phosphorylation and regulated expression of the human thromboxane A2 receptor. J Biol Chem 269:29914\u201329919;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR85","doi-asserted-by":"crossref","first-page":"26011","DOI":"10.1016\/S0021-9258(19)74486-X","volume":"268","author":"I Knezevic","year":"1993","unstructured":"Knezevic I, Borg C, LeBreton GC. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2\/prostaglandin H2 receptors. J Biol Chem 268:26011\u201326017;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR86","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0006-291X(83)91702-3","volume":"112","author":"EC Ku","year":"1983","unstructured":"Ku EC, McPherson SE, Signor C, Chertock H, Cash WD. Characterization of imidazole [1,5a]pyridine-5-hexanoic acid (CGS13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models. Biochem Biophys Res Commun 112;899\u2013906;1983.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR87","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood.V57.3.545.545","volume":"57","author":"B Lages","year":"1981","unstructured":"Lages B, Malmsten C, Weiss HJ, Samuelsson B. Impaired platelet response to thromboxane A2 and defective calcium mobilization in a patient with a bleeding disorder. Blood 57:545\u2013552;1981.","journal-title":"Blood"},{"key":"BF02253465_CR88","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1073\/pnas.76.8.4097","volume":"76","author":"GC LeBreton","year":"1979","unstructured":"LeBreton GC, Venton DL, Enke SE, Halushka PV. 13-Azaprostanoic acid: A specific antagonist of the human blood platelet thromboxane\/endoperoxide receptor. Proc Natl Acad Sci USA 76:4097\u20134101;1979.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR89","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/hmg\/4.suppl_1.1757","volume":"4","author":"DH Ledbetter","year":"1995","unstructured":"Ledbetter DH, Engel E. Uniparental disomy in humans; development of an imprinting map and its implications for parental diagnosis. Hum Mol Genet 4:1757\u20131764;1995.","journal-title":"Hum Mol Genet"},{"key":"BF02253465_CR90","volume-title":"Transcriptional regulation of the human thromboxane synthase gene expression","author":"KD Lee","year":"1996","unstructured":"Lee KD. Transcriptional regulation of the human thromboxane synthase gene expression; PhD Diss, University of Maryland, Baltimore, 1996."},{"key":"BF02253465_CR91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.1994.1712","volume":"201","author":"KD Lee","year":"1994","unstructured":"Lee KD, Baek SJ, Shen R-F. Cloning and characterization of the human thromboxane synthase promoter. Biochem Biophys Res Commun 201:379\u2013387;1994.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR92","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1042\/bj3190783","volume":"319","author":"KD Lee","year":"1996","unstructured":"Lee KD, Baek SJ, Shen R-F. Multiple factors regulating the expression of human thromboxane synthase gene. Biochem J 319:783\u2013791;1996.","journal-title":"Biochem J"},{"key":"BF02253465_CR93","first-page":"144","volume":"46","author":"AM Lefer","year":"1987","unstructured":"Lefer AM, Darius H. A pharmacological approach to thromboxane receptor antagonism. Fed Proc 46:144\u2013148;1987.","journal-title":"Fed Proc"},{"key":"BF02253465_CR94","first-page":"1133","volume":"247","author":"N Liel","year":"1988","unstructured":"Liel N, Mais DE, Halushka PV. Desensitization of the platelet thromboxane A2\/prostaglandin H2 receptors by the mimetic U-46619. J Pharmacol Exp Ther 247:1133\u20131138;1988.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0049-3848(93)90126-9","volume":"70","author":"N Liel","year":"1993","unstructured":"Liel N, Nathan I, Yermiyahu T, Zolotov Z, Lieberman JR, Dvilansky A, Halushka PV. Increased platelet thromboxane A2\/prostaglandin H2 receptors in patient with pregnancy induced hypertension. Thromb Res 70:205\u2013210;1993.","journal-title":"Thromb Res"},{"key":"BF02253465_CR96","first-page":"A162","volume":"9","author":"F Liu","year":"1995","unstructured":"Liu F, Wu JY, Orr JA. Thromboxane A2-induced pulmonary artery contraction is regulated by pertussis toxin sensitive G-proteins. FASEB J 9:A162;1995.","journal-title":"FASEB J"},{"key":"BF02253465_CR97","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-291X(85)91432-9","volume":"129","author":"Y Liu","year":"1985","unstructured":"Liu Y, Yoden K, Shen R-F, Tai HH. 12-L-Hydroxy-5,8,10-heptadecatrienoic acid (HHT) is an excellent substrate for NAD+-dependent 15-hydroxy-prostaglandin dehydrogenase. Biochem Biophys Res Commun 129:268\u2013274;1985.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR98","first-page":"221","volume":"31","author":"JE Macdonald","year":"1996","unstructured":"Macdonald JE. Nitric oxide synthase inhibitors. Ann Rep Med Chem 31:221\u2013230;1996.","journal-title":"Ann Rep Med Chem"},{"key":"BF02253465_CR99","first-page":"109","volume":"148","author":"DE Mais","year":"1988","unstructured":"Mais DE, DeHoli D, Sightler H, Halushka PV. Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol 148:109\u2013315;1988.","journal-title":"Eur J Pharmacol"},{"key":"BF02253465_CR100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(85)90121-9","volume":"111","author":"DE Mais","year":"1985","unstructured":"Mais DE, Dunlap C, Hamanaka N, Halushka PV. Further studies on the effect of epimers of thromboxane A2 antagonists on platelets and veins. Eur J Pharmacol 111:125\u2013128;1985.","journal-title":"Eur J Pharmacol"},{"key":"BF02253465_CR101","first-page":"418","volume":"233","author":"DE Mais","year":"1985","unstructured":"Mais DE, Saussy D, Chaikhouni A, Kochel P, Knapp D, Hamanaka N, Halushka PV. Pharmacologic characterization of human and canine thromboxane A2\/prostaglandin H2 receptors in platelets and blood vessels: Evidence for different receptors. J Pharmacol Exp Ther 233:418\u2013424;1985.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR102","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0922-4106(92)90004-F","volume":"227","author":"DE Mais","year":"1992","unstructured":"Mais DE, True TA, Martinelli MJ. Characterization by photoaffinity labeling of the human platelet thromboxane A2\/prostaglandin H2 receptor: Evidence for N-linked glycosylation. Eur J Pharmacol 227:267\u2013274;1992.","journal-title":"Eur J Pharmacol"},{"key":"BF02253465_CR103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0024-3205(76)90021-7","volume":"18","author":"C Malmsten","year":"1976","unstructured":"Malmsten C. Some biological effects of prostaglandin endoperoxide analogues. Life Sci 18:169\u2013176;1976.","journal-title":"Life Sci"},{"key":"BF02253465_CR104","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.1074\/jbc.272.26.16490","volume":"272","author":"MG Marini","year":"1997","unstructured":"Marini MG, Chan K, Casula L, Kan YW, Cao A, Moi P. HMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J Biol Chem 272:16490\u201316497;1997.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR105","doi-asserted-by":"crossref","first-page":"17478","DOI":"10.1016\/S0021-9258(19)85359-0","volume":"268","author":"PA Marsden","year":"1993","unstructured":"Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi X-M, Tsui L-C, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478\u201317488;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR106","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/344444a0","volume":"344","author":"DIK Martin","year":"1990","unstructured":"Martin DIK, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature 344:444\u2013447;1990.","journal-title":"Nature"},{"key":"BF02253465_CR107","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0006-2952(91)90316-W","volume":"42","author":"A Masuda","year":"1989","unstructured":"Masuda A, Mais DE, Oatis JJ, Halushka PV. Platelet and vascular thromboxane A2\/prostaglandin H2 receptor: Evidence for different subclasses in the rat. Biochem Pharmacol 42:537\u2013544;1989.","journal-title":"Biochem Pharmacol"},{"key":"BF02253465_CR108","first-page":"E928","volume":"265","author":"K Masuda","year":"1994","unstructured":"Masuda K, Mathur RS, Duzic E, Halushka PV. Androgen regulation of thromboxane A2\/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol 265:E928-E934;1994.","journal-title":"Am J Physiol"},{"key":"BF02253465_CR109","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.69.3.638","volume":"69","author":"A Masuda","year":"1991","unstructured":"Masuda A, Mathur R, Halushka PV. Testosterone increases thromboxane A2 receptors in cultures rat aortic smooth muscle cells. Circ Res 69:638\u2013643;1991.","journal-title":"Circ Res"},{"key":"BF02253465_CR110","first-page":"H887","volume":"267","author":"K Masuda","year":"1993","unstructured":"Masuda K, Ruff A, Morinelli TA, Mathur RS, Halushka PV. Testosterone increases thromboxane A2 receptor density in rat aortas and platelets. Am J Physiol 267:H887-H893;1993.","journal-title":"Am J Physiol"},{"key":"BF02253465_CR111","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(80)90642-X","volume":"i","author":"F Mestel","year":"1980","unstructured":"Mestel F, Oetliker O, Beck E, Felix R, Imbach P, Wagner H-P. Severe bleeding association with defective thromboxane synthase. Lancet i:157;1980.","journal-title":"Lancet"},{"key":"BF02253465_CR112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1432-1033.1994.00273.x","volume":"224","author":"A Miyata","year":"1994","unstructured":"Miyata A, Yokoyama C, Ihara H, Bandoh S, Takeda O, Takahashi E, Tanabe T. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur J Biochem 224:273\u2013279;1994.","journal-title":"Eur J Biochem"},{"key":"BF02253465_CR113","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","volume":"91","author":"P Moi","year":"1994","unstructured":"Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the \u03b2-globin locus control region. Proc Natl Acad Sci USA 91:9926\u20139930;1994.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR114","first-page":"293","volume":"30","author":"S Moncada","year":"1982","unstructured":"Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30:293\u2013333;1982.","journal-title":"Pharmacol Rev"},{"key":"BF02253465_CR115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/0024-3205(90)90140-M","volume":"46","author":"TA Morinelli","year":"1990","unstructured":"Morinelli TA, Mais DE, Oatis JJ, Crumbley AJ, Halushka PV. Characterization of thromboxane A2\/prostaglandin H2 receptors in human vascular smooth muscle cells. Life Sci 46:1765\u20131772;1990.","journal-title":"Life Sci"},{"key":"BF02253465_CR116","first-page":"H1035","volume":"253","author":"TA Morinelli","year":"1987","unstructured":"Morinelli TA, Niewiarowski S, Daniel JL, Smith JB. Receptor mediated effects of a PGH2 analog (U-46619) on human platelets. Am J Physiol 253:H1035-H1043;1987.","journal-title":"Am J Physiol"},{"key":"BF02253465_CR117","first-page":"557","volume":"251","author":"TA Morinelli","year":"1989","unstructured":"Morinelli TA, Oatis JJ, Okwu AK, Mais DE, Mayeux PR, Masuda A, Knapp DC, Halushka PV. Characterization of an [125I]-labelled thromboxane A2\/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther 251:557\u2013562;1989.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR118","first-page":"102","volume":"20","author":"TA Morinelli","year":"1990","unstructured":"Morinelli TA, Oatis JJ, Okwu AK, Mais DE, Mayeux PR, Masuda A, Knapp DC, Halushka PV. I-BOP, the most potent radiolabelled agonist for the TXA2\/PGH2 receptor. Adv Prostaglandin Thromboxane Leukot Res 20:102\u2013109;1990.","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"BF02253465_CR119","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/S0021-9258(17)37516-6","volume":"269","author":"TA Morinelli","year":"1993","unstructured":"Morinelli TA, Zhang LM, Newman WH, Meier KE. Thromboxane A2\/prostaglandin H2 stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem 269:5693\u20135698;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-6980(92)90077-7","volume":"44","author":"JD Morrow","year":"1992","unstructured":"Morrow JD, Minton TA, Roberts LJ. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane\/endoperoxide receptor, is a platelet thromboxane\/endoperoxide receptor antagonist. Prostaglandins 44:155\u2013163;1992.","journal-title":"Prostaglandins"},{"key":"BF02253465_CR121","doi-asserted-by":"crossref","first-page":"21670","DOI":"10.1016\/S0021-9258(18)45792-4","volume":"265","author":"R Murray","year":"1990","unstructured":"Murray R, Shipp E, FitzGerald GA. Prostaglandin endoperoxide\/thromboxane A2 receptor desensitization: Crosstalk with adenylate cyclase in human platelets. J Biol Chem 265:21670\u201321675;1990.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR122","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0262-1746(87)90141-7","volume":"30","author":"H Nagai","year":"1987","unstructured":"Nagai H, Yokuo I, Togawa M, Arimura A, Matsuura N, Koda A, Hamano S, Ujie A, Nakazawa M. Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs. Prostaglandins Leukot Med 30:111\u2013121;1987.","journal-title":"Prostaglandins Leukot Med"},{"key":"BF02253465_CR123","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0006-291X(05)80009-9","volume":"184","author":"T Namba","year":"1992","unstructured":"Namba T, Sugimoto Y, Hirata M, Hayashi Y, Honda A, Watabe A, Negishi M, Ichikawa A, Narumiya S. Mouse thromboxane A2 receptor: cDNA, cloning expression and northern blot analysis. Biochem Biophys Res Commun 184:1197\u20131203;1992.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR124","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1146\/annurev.bi.56.070187.004501","volume":"56","author":"DW Nebert","year":"1987","unstructured":"Nebert DW, Gonzalez FJ. P-450 genes: Structure, evolution and regulation. Annu Rev Biochem 56:945\u2013993;1987.","journal-title":"Annu Rev Biochem"},{"key":"BF02253465_CR125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dna.1991.10.1","volume":"10","author":"DW Nebert","year":"1991","unstructured":"Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fuji-Kuriyama Y, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ. The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 10:1\u201314;1991.","journal-title":"DNA Cell Biol"},{"key":"BF02253465_CR126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.945611","volume":"193","author":"P Needleman","year":"1976","unstructured":"Needleman P, Minkes M, Raz A. Thromboxanes: Selective biosynthesis and distinct biological activities. Science 193:163\u2013165;1976.","journal-title":"Science"},{"key":"BF02253465_CR127","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/261558a0","volume":"261","author":"P Needleman","year":"1976","unstructured":"Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B. Identification of an enzyme in platelet microsomes which generates TXA2 from prostaglandin endoperoxides. Nature 261:558\u2013560;1976.","journal-title":"Nature"},{"key":"BF02253465_CR128","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.76.2.944","volume":"76","author":"P Needleman","year":"1976","unstructured":"Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H. Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological activities. Proc Natl Acad Sci USA 76:944\u2013948;1976.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0929-7855(95)00024-K","volume":"12","author":"M Negishi","year":"1995","unstructured":"Negishi M, Sugimoto Y, Ichikawa A. Prostaglandin E receptors. J Lipid Mediat Cell Signal 12:379\u2013391;1995.","journal-title":"J Lipid Mediat Cell Signal"},{"key":"BF02253465_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","volume":"6","author":"DR Nelson","year":"1996","unstructured":"Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1\u201342;1996.","journal-title":"Pharmacogenetics"},{"key":"BF02253465_CR131","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1073\/pnas.76.6.2566","volume":"76","author":"KC Nicolaou","year":"1979","unstructured":"Nicolaou KC, Magolda RI, Smith JB. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation and thromboxane formation. Proc Natl Acad Sci USA 76:2566\u20132570;1979.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)81744-K","volume":"316","author":"S Nigam","year":"1993","unstructured":"Nigam S, Eskafi S, Roscher A, Weitzel H. Thromboxane A2 analogue U-46619 enhances tumor cell proliferation in HeLa cells via specific receptors which are apparently distinct from TXA2 receptors on human platelets. FEBS Lett 316:99\u2013102;1993.","journal-title":"FEBS Lett"},{"key":"BF02253465_CR133","first-page":"53","volume":"3","author":"R N\u00fcsing","year":"1990","unstructured":"N\u00fcsing R, Lesch R, Ullrich V. Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 3:53\u201358;1990.","journal-title":"Eicosanoids"},{"key":"BF02253465_CR134","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01611182","volume":"421","author":"R N\u00fcsing","year":"1992","unstructured":"N\u00fcsing R, Sauter G, Fehr P, D\u00fcrm\u00fcller U, Kasper M, Gudat F, Ullrich V. Localization of thromboxane synthase in human tissues by monoclonal antibody T\u00fc300. Pathol Anat Histopathol 421:249\u2013254;1992.","journal-title":"Pathol Anat Histopathol"},{"key":"BF02253465_CR135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0003-9861(90)90337-X","volume":"280","author":"R N\u00fcsing","year":"1990","unstructured":"N\u00fcsing R, Schneider-Voss S, Ullrich V. Immunoaffinity purification of human thromboxane synthase. Arch Biochem Biophys 280:325\u2013330;1990.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR136","doi-asserted-by":"crossref","first-page":"25252","DOI":"10.1016\/S0021-9258(19)74595-5","volume":"268","author":"RM N\u00fcsing","year":"1993","unstructured":"N\u00fcsing RM, Hirata M, Kakizuka A, Eki T, Ozawa K, Narumiya S. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J Biol Chem 268:25252\u201325259;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR137","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1073\/pnas.91.2.504","volume":"91","author":"S Offermanns","year":"1994","unstructured":"Offermanns S, Langwitz KL, Spicher K, Schultz G. G-proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91:504\u2013508;1994.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02253465_CR138","first-page":"133","volume":"46","author":"ML Ogletree","year":"1987","unstructured":"Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46:133\u2013138;1987.","journal-title":"Fed Proc"},{"key":"BF02253465_CR139","first-page":"435","volume":"234","author":"ML Ogletree","year":"1985","unstructured":"Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakano M. Pharmacologic actions of SQ-29548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234:435\u2013441;1985.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0021-9258(18)48353-6","volume":"267","author":"K Ohashi","year":"1992","unstructured":"Ohashi K, Ruan KH, Kulmacz RJ, Wu KK, Wang LH. Primary structure of human thromboxane synthase determined from the cDNA sequence. J Biol Chem 267:789\u2013793;1992.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR141","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/S0040-4020(01)88649-X","volume":"39","author":"S Ohuchida","year":"1983","unstructured":"Ohuchida S, Hamanaka N, Hayashi M. Synthesis of thromboxane A2 analogs-2: (+\/\u2212) Thiathromboxane A2. Tetrahedron 39:4263\u20134268;1983.","journal-title":"Tetrahedron"},{"key":"BF02253465_CR142","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-4889(94)90220-8","volume":"1221","author":"AK Okwu","year":"1994","unstructured":"Okwu AK, Mais DE, Halushka PV. Agonist induced phosphorylation of human platelet TXA2\/PGH2 receptors. Biochim Biophys Acta 1221:83\u201388;1994.","journal-title":"Biochim Biophys Acta"},{"key":"BF02253465_CR143","first-page":"238","volume":"262","author":"AK Okwu","year":"1992","unstructured":"Okwu AK, Ullian ME, Halushka PV. Homologous desensitization of human platelet thromboxane A2\/prostaglandin H2 receptors. J Pharmacol Exp Ther 262:238\u2013245;1992.","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl IV","key":"BF02253465_CR144","first-page":"139","volume":"21","author":"H Patcheke","year":"1990","unstructured":"Patcheke H. Thromboxane A2\/prostaglandin H2 receptor antagonists: A new therapeutic principle. Stroke 21 (suppl IV):139\u2013142;1990.","journal-title":"Stroke"},{"key":"BF02253465_CR145","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","volume":"330","author":"C Patrono","year":"1994","unstructured":"Patrono C. Aspirin as an anti-platelet drug. New Engl J Med 330:1287\u20131294;1994.","journal-title":"New Engl J Med"},{"key":"BF02253465_CR146","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/bj2980537","volume":"298","author":"B Pichon","year":"1994","unstructured":"Pichon B, Christophe-Hobertus C, Vassart G, Christopher D. Unmethylated thyroglobulin promoter may be repressed by methylation of flanking DNA sequences. Biochem J 298:537\u2013541;1994.","journal-title":"Biochem J"},{"key":"BF02253465_CR147","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/223029a0","volume":"223","author":"PJ Piper","year":"1969","unstructured":"Piper PJ, Vane JR. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223:29\u201335;1969.","journal-title":"Nature"},{"key":"BF02253465_CR148","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1016\/S0021-9258(17)38613-1","volume":"260","author":"G Pugliese","year":"1985","unstructured":"Pugliese G, Spokas EG, Marcinkiewicz E, Wong PYK. Hepatic transformation of prostaglandin D2 to a new prostanoid 9\u03b1,11\u03b2-prostaglandin F2 that inhibits platelet aggregation and constricts blood vessels. J Biol Chem 260:14621\u201314625;1985.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0049-3848(81)90247-4","volume":"23","author":"MJ Randall","year":"1981","unstructured":"Randall MJ, Parry MJ, Kawkeswood E, Cross PE, Dickinson RP. UK-37248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thromb Res 23:145\u2013162;1981.","journal-title":"Thromb Res"},{"key":"BF02253465_CR150","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1016\/S0021-9258(17)32161-0","volume":"269","author":"MK Raychowdhury","year":"1994","unstructured":"Raychowdhury MK, Yukawa M, Collins LJ, McGrall SH, Kent KC, Ware JA. Alternate splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem 269:19256\u201319261;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR151","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ki.1992.217","volume":"41","author":"G Remuzzi","year":"1992","unstructured":"Remuzzi G, FitzGerald GA, Patrono C. Thromboxane synthesis and action within the kidney. Kidney Int 41:1483\u20131493;1992.","journal-title":"Kidney Int"},{"key":"BF02253465_CR152","first-page":"327","volume":"4","author":"PK Rogan","year":"1987","unstructured":"Rogan PK, Pan J, Weissman SM. L1 repeat elements in the human \u03b5-\u03b3-globin gene intergenic region: Sequence analysis and concerted evolution within this family. Mol Biol Evol 4:327\u2013342;1987.","journal-title":"Mol Biol Evol"},{"key":"BF02253465_CR153","doi-asserted-by":"crossref","first-page":"20938","DOI":"10.1016\/S0021-9258(17)31912-9","volume":"269","author":"K-H Ruan","year":"1994","unstructured":"Ruan K-H, Li P, Kulmacz RJ, Wu KK. Characterization of the structure and membrane interaction of NH2-terminal domain of thromboxane A2 synthase. J Biol Chem 269:20938\u201320942;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR154","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/protein\/7.11.1345","volume":"7","author":"KH Ruan","year":"1994","unstructured":"Ruan KH, Milfeld K, Kulmacz RJ, Wu KK. Comparison of the construction of a 3-D model for human thromboxane synthase using P450cam and BM-3 as templates: Implications for the substrate binding pocket. Protein Eng 7:1345\u20131351;1994.","journal-title":"Protein Eng"},{"key":"BF02253465_CR155","doi-asserted-by":"crossref","first-page":"19483","DOI":"10.1016\/S0021-9258(19)36541-X","volume":"268","author":"K-H Ruan","year":"1993","unstructured":"Ruan K-H, Wang L-H, Wu KK, Kulmacz RJ. Amino-terminal topology of thromboxane synthase in the endoplasmic reticulum. J Biol Chem 268:19483\u201319490;1993.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR156","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.1981.tb02715.x","volume":"48","author":"M Samama","year":"1981","unstructured":"Samama M, Lecrubier C, Conard J, Hotchen M, Breton-Gorius J, Vargaftig B, Chignard M, Lagarde M, Dechavanne M. Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol 48:293\u2013303;1981.","journal-title":"Br J Haematol"},{"key":"BF02253465_CR157","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1242\/dev.111.2.573","volume":"111","author":"H Sasaki","year":"1991","unstructured":"Sasaki H, Hamada T, Ueda T, Seki R, Higashinakagawa T, Sakaki Y. Inherited type of allelic methylation variations in a mouse chromosome region where an integrated transgene shows methylation imprinting. Development 111:573\u2013581;1991.","journal-title":"Development"},{"key":"BF02253465_CR158","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1101\/gad.6.10.1843","volume":"6","author":"H Sasaki","year":"1992","unstructured":"Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith AC, Barton S, Reik W, Surani MA. Parental imprinting: Potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev 6:1843\u20131856;1992.","journal-title":"Genes Dev"},{"key":"BF02253465_CR159","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/geno.1993.1457","volume":"18","author":"DA Schwengel","year":"1993","unstructured":"Schwengel DA, Nouri N, Meyers DA, Levitt RC. Linkage mapping of the human thromboxane receptor (TBXA2R) to chromosome 19p13.3 using transcribed 3\u2032-untranslated DNA sequence polymorphisms. Genomics 18:212\u2013218;1993.","journal-title":"Genomics"},{"key":"BF02253465_CR160","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/01.RES.67.6.1562","volume":"67","author":"WC Sessa","year":"1990","unstructured":"Sessa WC, Halushka PV, Okwu A, Nasjletti A. Characterization of the vascular thromboxane A2\/prostaglandin endoperoxide receptor in rabbit aorta: Regulation by dexamethasone. Circ Res 67:1562\u20131569;1990.","journal-title":"Circ Res"},{"key":"BF02253465_CR161","unstructured":"Shen R-F. Thromboxane synthase: Purificatin, characterization and immunological studies. PhD Diss, University of Kentucky, 1985."},{"key":"BF02253465_CR162","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1016\/S0021-9258(18)67283-7","volume":"261","author":"R-F Shen","year":"1986","unstructured":"Shen R-F, Tai HH. Monoclonal antibodies to thromboxane synthase from porcine lung. Production and application to development of a tandem immunoradiometric assay. J Biol Chem 261:11585\u201311591;1986.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR163","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1016\/S0021-9258(18)67284-9","volume":"261","author":"R-F Shen","year":"1986","unstructured":"Shen R-F, Tai HH. Immunoaffinity purification and characterization of thromboxane synthase from porcine lung. J Biol Chem 261:11592\u201311599;1986.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR164","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0378-1119(94)90555-X","volume":"140","author":"R-F Shen","year":"1994","unstructured":"Shen R-F, Zhang L, Baek SJ, Tai HH, Lee K-D. The porcine thromboxane synthase-encoding cDNA: Molecular cloning, mRNA expression, and enzyme production in Sf9 insect cells. Gene 140:261\u2013265;1994.","journal-title":"Gene"},{"key":"BF02253465_CR165","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1016\/S0021-9258(18)31586-2","volume":"266","author":"A Shenker","year":"1991","unstructured":"Shenker A, Goldsmith P, Unson CG, Spiegel AM. The G-protein coupled to the thromboxane receptor in human platelets is a member of the novel Gq family. J Biol Chem 266:9309\u20139313;1991.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR166","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(85)90414-5","volume":"109","author":"Y Shibouta","year":"1985","unstructured":"Shibouta Y, Terashita ZN, Inada Y, Nishikawa K. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor. Eur J Pharmacol 109:135\u2013144;1985.","journal-title":"Eur J Pharmacol"},{"key":"BF02253465_CR167","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jlb.53.2.173","volume":"53","author":"TR Simmons","year":"1993","unstructured":"Simmons TR, Cook JA, Moore JN, Halushka PV. Thromboxane A2 receptors in equine monocytes: Identification of a new subclass of TXA2 receptors. J Leuk Biol 53:173\u2013178;1993.","journal-title":"J Leuk Biol"},{"key":"BF02253465_CR168","first-page":"59","volume":"3","author":"H Sinzinger","year":"1990","unstructured":"Sinzinger H, O'Grady J, Demers LM, Granstr\u00f6m E, Kumlin M, Nell A, Peskar BA, Salmon JA, Westlund P. Thromboxane in cardiovascular disease. Eicosanoids 3:59\u201364;1990.","journal-title":"Eicosanoids"},{"key":"BF02253465_CR169","first-page":"199","volume":"2","author":"EF Smith III","year":"1989","unstructured":"Smith EF III. Thromboxane A2 in cardiovascular and renal disorders: Is there a defined role of thromboxane receptor antagonists or thromboxane synthase inhibitors? Eicosanoids 2:199\u2013211;1989.","journal-title":"Eicosanoids"},{"key":"BF02253465_CR170","first-page":"139","volume":"46","author":"JB Smith","year":"1987","unstructured":"Smith JB. Pharmacology of thromboxane synthetase inhibitors. Fed Proc 46:139\u2013143;1987.","journal-title":"Fed Proc"},{"key":"BF02253465_CR171","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/jm00149a007","volume":"28","author":"PW Sprague","year":"1985","unstructured":"Sprague PW, Heikes JE, Gougoutas JZ, Malley MF, Harris DN, Greenberg R. Synthesis and in vitro pharmacology of 7-oxabicyclo [2.2.1]heptane analogues of thromboxane A2\/PGH2. J Med Chem 28:1580\u20131590;1985.","journal-title":"J Med Chem"},{"key":"BF02253465_CR172","first-page":"584","volume":"264","author":"RF Spurney","year":"1993","unstructured":"Spurney RF, Onorato JJ, Ruiz P, Pisetsky DS, Coffman TM. Characterization of glomerular thromboxane receptors in murine lupus nephritis. J Pharmacol Exp Ther 264:584\u2013590;1993.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR173","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0090-6980(77)90285-4","volume":"14","author":"FF Sun","year":"1977","unstructured":"Sun FF, Chapman JP, McGuire JC. Metabolism of prostaglandin endoperoxides in animal tissues. Prostaglandins 14:1055\u20131074;1977.","journal-title":"Prostaglandins"},{"key":"BF02253465_CR174","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4899-1813-0_31","volume":"407","author":"HH Tai","year":"1996","unstructured":"Tai HH, Huang CF, Chiang N. Structure and function of prostanoid receptors as revealed by site-directed mutagenesis. Adv Exp Med Biol 407:205\u2013209;1996.","journal-title":"Adv Exp Med Biol"},{"key":"BF02253465_CR175","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0003-9861(80)90236-2","volume":"203","author":"HH Tai","year":"1980","unstructured":"Tai HH, Tai CL, Lee N. Selective inhibition of thromboxane synthetase by pyridine and its derivatives. Arch Biochem Biophys 203:758\u2013763;1980.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR176","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0003-2697(78)90683-8","volume":"87","author":"HH Tai","year":"1978","unstructured":"Tai HH, Yuan B. Development of radioimmunoassay for thromboxane B2. Anal Biochem 87:343\u2013349;1978.","journal-title":"Anal Biochem"},{"key":"BF02253465_CR177","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-291X(78)91128-2","volume":"80","author":"HH Tai","year":"1978","unstructured":"Tai HH, Yuan B. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem Biophys Res Commun 80:236\u2013242;1978.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR178","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1016\/S0021-9258(19)39224-5","volume":"265","author":"K Takahara","year":"1990","unstructured":"Takahara K, Murray R, FitzGerald GA, Firgerald DJ. The response to thromboxane A2 analogues in human platelets: Discrimination of two binding sites linked to distinct effector systems. J Biol Chem 265:6836\u20136844;1990.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR179","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1210\/endo.136.9.7649122","volume":"136","author":"N Takahashi","year":"1995","unstructured":"Takahashi N, Takeuchi K, Abe T, Murakami K, Yamaguchi M, Abe K. Immunohistochemical localization of thromboxane receptor and thromboxane synthase in rat testis. Endocrinology 136:4143\u20134146;1995.","journal-title":"Endocrinology"},{"key":"BF02253465_CR180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1006\/geno.1994.1113","volume":"19","author":"M Taketo","year":"1994","unstructured":"Taketo M, Rochelle JM, Sugimoto Y, Namba T, Honda A, Negishi M, Ichikawa A, Narumiya S, Seldin MF. Mapping of the genes encoding mouse thromboxane A2 receptor and prostaglandin E receptor subtypes EP2 and EP3. Genomics 19:585\u2013588;1994.","journal-title":"Genomics"},{"key":"BF02253465_CR181","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0929-7855(95)00031-K","volume":"12","author":"T Tanabe","year":"1995","unstructured":"Tanabe T, Ullrich V. Prostacyclin and thromboxane synthases. J Lipid Mediators Cell Signalling 12:243\u2013256;1995.","journal-title":"J Lipid Mediators Cell Signalling"},{"key":"BF02253465_CR182","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/abbi.1996.0464","volume":"334","author":"R Tazawa","year":"1996","unstructured":"Tazawa R, Green ED, Ohashi K, Wu KK, Wang L-H. Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter. Arch Biochem Biophys 334:349\u2013356;1996.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR183","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-5793(94)80146-0","volume":"340","author":"Y Tone","year":"1994","unstructured":"Tone Y, Miyata A, Hara S, Yukawa S, Tanabe T. Abundant expression of thromboxane synthase in rat macrophages. FEBS Lett 340:241\u2013244;1994.","journal-title":"FEBS Lett"},{"key":"BF02253465_CR184","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1006\/bbrc.1996.0307","volume":"219","author":"T Toki","year":"1997","unstructured":"Toki T, Itoh J, Arai K, Kitazawa J, Yokoyama M, Igarashi K, Yamamoto M, Ito E. Abundant expression of erythroid transcription factor p45 NF-E2 mRNA in human peripheral granulocytes. Biochem Biophys Res Commun 219:760\u2013765;1997.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR185","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.178.5.1825","volume":"178","author":"F Ushikubi","year":"1993","unstructured":"Ushikubi F, Aiba Y, Nakamura K, Namba T, Hirata M, Mazda O, Katsura Y, Narumiya S. Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med 178:1825\u20131830;1993.","journal-title":"J Exp Med"},{"key":"BF02253465_CR186","doi-asserted-by":"crossref","first-page":"16496","DOI":"10.1016\/S0021-9258(19)84733-6","volume":"264","author":"F Ushikubi","year":"1989","unstructured":"Ushikubi F, Nakajima M, Hirata M, Okuma M, Fujiwara M, Narumiya S. Purification of the thromboxane A2\/prostaglandin H2 receptor from human blood platelets. J Biol Chem 264:16496\u201316501;1989.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR187","first-page":"808","volume":"46","author":"F Ushikubi","year":"1994","unstructured":"Ushikubi F, Nakamura K, Narumiya S. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles. Mol Pharmacol 46:808\u2013816;1994.","journal-title":"Mol Pharmacol"},{"key":"BF02253465_CR188","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00542494","volume":"33","author":"F Violi","year":"1988","unstructured":"Violi F, Ghiselli A, Iuliano L, Pratico D, Alessandri C, Balsano F. Inhibition by picotamide of thromboxane production in vivo and in vitro. Eur J Clin Pharmacol 33:599\u2013602;1988.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02253465_CR189","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1016\/S0021-9258(17)37604-4","volume":"269","author":"T Voyno-Yasenetskaya","year":"1994","unstructured":"Voyno-Yasenetskaya T, Conklin BR, Gilbert RL, Hooley R, Bourne HR, Barber DL. G\u03b113 stimulates Na-H exchange. J Biol Chem 269:4721\u20134724;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR190","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1074\/jbc.271.33.19970","volume":"271","author":"L-H Wang","year":"1996","unstructured":"Wang L-H, Matijevic-Aleksic N, Hsu P-Y, Ruan K-H, Wu KK, Kulmacz RJ. Identification of thromboxane A2 synthase active site residues by molecular modeling-guided site-directed mutagenesis. J Biol Chem 271:19970\u201319975;1996.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR191","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/abbi.1994.1500","volume":"315","author":"L-H Wang","year":"1994","unstructured":"Wang L-H, Tazawa R, Lang A-Q, Wu KK. Alternate splicing of human thromboxane synthase mRNA. Arch Biochem Biophys 315:273\u2013278;1994.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR192","doi-asserted-by":"crossref","first-page":"17619","DOI":"10.1016\/S0021-9258(17)32486-9","volume":"269","author":"T Watanabe","year":"1994","unstructured":"Watanabe T, Nakano A, Emerling D, Hashimoto Y, Tsukamoto K, Horie Y, Kinoshita M, Kurokawa K. Prostaglandin F2\u03b1 enhances tyrosine phosphorylation and DNA synthesis through phospholipase C-coupled receptor via Ca2+ dependent intracellular pathway in NIH-3T3 cells. J Biol Chem 269:17619\u201317625;1994.","journal-title":"J Biol Chem"},{"key":"BF02253465_CR193","first-page":"1387","volume":"264","author":"ML Webb","year":"1993","unstructured":"Webb ML, Liu EC, Monshizadegan H, Hedberg A, Misra RN, Goldberg H, Harris DN. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets. J Pharmacol Exp Ther 264:1387\u20131394;1993.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253465_CR194","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(77)92213-9","volume":"ii","author":"HJ Weiss","year":"1977","unstructured":"Weiss HJ, Lages BA. Possible congenital defect in platelet thromboxane synthetase. Lancet ii:760\u2013761;1977.","journal-title":"Lancet"},{"key":"BF02253465_CR195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/292472a0","volume":"292","author":"BRJ Whittle","year":"1981","unstructured":"Whittle BRJ, Kauffman GL, Moncada S. Ulceration of the gastric mucosa following vasoconstriction with thromboxane A2. Nature 292:472\u2013474;1981.","journal-title":"Nature"},{"key":"BF02253465_CR196","first-page":"1225","volume":"78","author":"SH Woodworth","year":"1994","unstructured":"Woodworth SH, Li X, Lei ZM, Rao ChV, Yussman MA, Spinnato II JA, Yokoyama C, Tanabe T, Ullrich V. Eicosanoid biosynthetic enzymes in placental and decidual tissues from pre-eclamptic pregnancies: Increased expression of thromboxane-A2 synthase gene. J Clin Endocrinol Metab 78:1225\u20131231;1994.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02253465_CR197","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1172\/JCI110221","volume":"67","author":"KK Wu","year":"1981","unstructured":"Wu KK, Le Breton GC, Tai HH, Chen YC. Abnormal platelet response to thromboxane A2. J Clin Invest 67:1801\u20131804;1981.","journal-title":"J Clin Invest"},{"key":"BF02253465_CR198","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1981.tb02785.x","volume":"47","author":"KK Wu","year":"1981","unstructured":"Wu KK, Minkoff IM, Rossi EC, Chen YC. Hereditary bleeding disorder due to a primary defect in a platelet release reaction. Br J Haematol 47:241\u2013249;1981.","journal-title":"Br J Haematol"},{"key":"BF02253465_CR199","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj2950457","volume":"295","author":"Z Xia","year":"1993","unstructured":"Xia Z, Shen R-F, Baek SJ, Tai H-H. Expression of two different forms of cDNA for thromboxane synthase in insect cells and site-directed mutagenesis of a critical cysteine residue. Biochem J 295:457\u2013461;1993.","journal-title":"Biochem J"},{"key":"BF02253465_CR200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1006\/abbi.1995.1427","volume":"321","author":"ZN Xia","year":"1995","unstructured":"Xia ZN, Tai HH. Bacterial expression of functional membrane bound thromboxane synthase lacking its hydrophobic N-terminal segment. Arch Biochem Biophys 321:531\u2013534;1995.","journal-title":"Arch Biochem Biophys"},{"key":"BF02253465_CR201","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/jm00059a005","volume":"36","author":"Y Yamamoto","year":"1993","unstructured":"Yamamoto Y, Kaniya K, Terao S. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J Med Chem 36:820\u2013825;1993.","journal-title":"J Med Chem"},{"key":"BF02253465_CR202","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/0006-291X(91)91060-P","volume":"178","author":"C Yokoyama","year":"1991","unstructured":"Yokoyama C, Miyata A, Ihara H, Ullrich V, Tanabe T. Molecular cloning of human thromboxane synthase. Biochem Biophys Res Commun 178:1474\u20131484;1991.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-5793(93)81335-W","volume":"318","author":"C Yokoyama","year":"1993","unstructured":"Yokoyama C, Miyata A, Suzuki K, Nishikawa Y, Yoshimoto T, Yamamoto S, N\u00fcsing R, Ullrich V, Tanabe T. Expression of human thromboxane synthase using a baculovirus system. FEBS 318:91\u201394;1993.","journal-title":"FEBS"},{"key":"BF02253465_CR204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/cvr\/21.2.119","volume":"21","author":"Y Yui","year":"1987","unstructured":"Yui Y, Sakaguchi K, Susawa T, Hattori R, Takatsu Y, Yui N, Kawai C. Thromboxane A2 analogue induced coronary artery vasoconstriction in the rabbit. Cardiovasc Res 21:119\u2013123;1987.","journal-title":"Cardiovasc Res"},{"key":"BF02253465_CR205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1006\/bbrc.1993.1884","volume":"194","author":"L Zhang","year":"1993","unstructured":"Zhang L, Chase MB, Shen R-F. Molecular cloning and expression of murine thromboxane synthase. Biochem Biophys Res Commun 194:741\u2013748;1993.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02253465_CR206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1006\/geno.1997.4982","volume":"45","author":"L Zhang","year":"1997","unstructured":"Zhang L, Xiao H, Schultz RA, Shen R-F. Genomic organization, chromosomal localization and expression of the murine thromboxane synthase gene(Tbxas1). Genomics 45:519\u2013528;1997.","journal-title":"Genomics"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02253465\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/BF02253465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T04:11:18Z","timestamp":1626754278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02253465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":206,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["BF02253465"],"URL":"https:\/\/doi.org\/10.1007\/bf02253465","relation":{},"ISSN":["1021-7770","1423-0127"],"issn-type":[{"value":"1021-7770","type":"print"},{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}